While initial studies highlighted potential neuroprotective effects of CTSB, such as reducing amyloid-beta levels and improving cognition in Alzheimer’s disease models, recent evidence suggests its role may extend to promoting neurodegeneration [1097, 1098]. This evidence concerns the gene CTSB and Alzheimer disease.